Skip to content

Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?

Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01964118
Acronym
IF
Enrollment
50
Registered
2013-10-17
Start date
2013-07-31
Completion date
2016-09-30
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

intermittent fasting, obesity, calorie restriction

Brief summary

The purpose of Intermittent Fasting study is to investigate whether intermittent fasting could decrease the chronic inflammation levels in overweight/obese people.

Detailed description

The primary objective of this study is to determine whether or not IF reduces the level of chronic inflammation as evidenced by a decrease in high sensitive C-reactive protein (hsCRP), as the main outcome measure

Interventions

OTHERIntermittent Fasting group

Intermittent fasting for 12 months

OTHERcontrol group

usual diet for 6 months and intermittent fasting for other 6 months

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* The participants in this study will be 50 men and women in the 30 to 65 year age range, who have a BMI in the high normal to moderately obese range (i.e. 24 to 35 kg/m2), * Participants who are eating usual US diets and are sedentary to moderately active (i.e. not exercise trained).

Exclusion criteria

* History of any chronic disease process that could interfere with interpretation of results * Smoking, pregnancy, alcoholism, psychiatric problems, life situations that would interfere with study participation and compliance.

Design outcomes

Primary

MeasureTime frameDescription
Change in HSCRP ( high sensitivity C-reactive protein) at 6 and 12 monthsEvery 6 months- baseline, 6 month and 12 monthHSCRP would be measured in mg/L

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026